Is peptide dropshipping legal in the US?

There is no clean yes or no, and any supplier who gives you one should worry you. Dropshipping is a fulfillment arrangement — a decision about who holds inventory and who packs the box. It is not a legal category, and it does not by itself make a transaction permissible or impermissible. What determines your exposure is the identity of the compound, how it is labeled and described, who the buyer is, what claims appear anywhere in your funnel, and what your state and local regulators require of the entity taking the order. Research-use-only compounds sit under a different set of questions than anything positioned for human use. This article is informational and is not legal advice; the only answer you can rely on is the one your own attorney gives after reviewing your specific model.

Fulfillment is a logistics choice, not a legal category

Run the same catalog three ways — you stock it yourself, a partner ships on your behalf, or you split the difference — and the questions a regulator or a payment processor would ask are largely identical in all three. They ask what the product is. They ask what you said about it. They ask who is on the record as the seller. They ask whether the entity making the sale needed a registration, license, or permit to do so in the jurisdictions where orders landed.

None of those questions are answered by where the inventory sat. That is why buyers who arrive at this topic hoping that a dropship structure creates distance from the compliance burden usually leave disappointed. If anything, blind fulfillment moves the compliance burden closer to you while moving your visibility further away, because your brand is on the invoice and the listing, but you never see the vial. The structure changes your working capital and your operational risk profile. It does not change your obligations.

The questions your counsel has to answer first

Before you route a single order, there is a short list of things you need resolved in writing by a lawyer who knows your state and your entity type. Not resolved by a forum post, and not resolved by a supplier's marketing page.

Start with your entity. Does your business, as structured, need any registration or license to offer these products to buyers in the states you plan to ship to? The answer varies by state and by what kind of operation you are — a wellness business, a telehealth company, and a pure e-commerce reseller are not the same animal, and boards do not treat them the same way. Ask, do not assume.

Then the catalog. Is anything you plan to list a controlled substance, a restricted compound, or something with its own category-specific rules? That is a compound-by-compound question, not a category-wide one, and it needs to be re-asked whenever you add a SKU.

Then the transaction. Who is the seller of record when a partner ships the parcel? Whose name appears on the packing slip, and does that match what the buyer's receipt says? What do your terms of sale actually commit you to?

Then the plumbing. Your payment processor and your ad platforms impose acceptable-use rules that are contractual rather than statutory — but a processor's decision can end a business faster than a regulator's. Read those policies as carefully as you read the law.

If a supplier is shipping from outside the country, import questions enter the picture too. Ask your counsel what applies before volume makes the question expensive.

Claims are the fault line, not the shipping label

In practice, the thing that gets resellers in trouble in this category is almost never the warehouse arrangement. It is copy.

Research-use-only means the framing has to hold everywhere, not just on the product page footer. No dosing. No administration guidance. No indications, protocols, or before-and-after language. No testimonials describing what someone experienced. Where the underlying science is genuinely interesting, research suggests and studies indicate are the honest verbs, and the subject of the sentence stays the compound, not a person.

The hard part is the surface area you do not directly write. Affiliate pages, influencer captions, an email sequence a contractor drafted two years ago, a marketplace listing where the description field was auto-generated, a customer-service reply typed at speed. Every one of those is your copy for practical purposes. Any reseller serious about this builds a claims standard, trains anyone who writes to it, and audits the funnel on a schedule. A dropship model does not exempt you from this — it just means the compliant packaging arriving at your customer's door is being paired with whatever your website said, and only one of those two is under your control.

Three fulfillment models and the questions each one raises

Most resellers who scale past the experimental stage end up in the third row. They stock the handful of SKUs that move predictably, so they can inspect and document those themselves, and they let a partner cover catalog depth. The reason is not legal, it is operational: you cannot answer a customer's question about a lot you never touched unless your supplier gives you a way to look it up.

Where blind fulfillment quietly breaks down

The first crack is traceability. If a customer emails asking for the certificate of analysis matching the lot number on their vial, you need a way to produce it in minutes. If your supplier's COAs are generic, undated, unlinked to lot numbers, or available only on request behind a sales rep, you cannot. You now have a customer holding a product with your brand on the transaction and no documentation you can hand them.

The second is substitution. Backorders happen. What does your partner do when a SKU is out — hold the order, notify you, or quietly ship an alternative? Get that answer in writing before it happens, not after a customer receives something they did not order.

The third is label control. You did not print it, you did not read it, and it went out under your brand's shadow. If the label carries language that conflicts with your own research-use standard, you have inherited that inconsistency.

The fourth is simply distance. A supplier who ships direct to your customers is, functionally, your operations department. If they are slow, opaque, or unresponsive to a quality question, your customers experience that as your failure.

What to verify in any supplier before you route orders to them

Ask for a published purity specification, and ask what analytical method backs it. Purity by HPLC and identity by mass spectrometry answer different questions, and a supplier who cannot articulate the difference is not testing seriously.

Ask whether certificates of analysis are batch-level and tied to lot numbers, and whether you and your customers can pull them up without asking permission. Some operations sell COAs as an add-on or release them only to accounts that push back. Documentation you have to pay for or beg for is not documentation you can build a business on.

Ask who appears as seller of record and what shows up on the packing slip.

Ask where fulfillment originates, and whether every order actually ships from where the website implies.

Ask what happens when a batch fails testing. A real answer describes a quarantine and disposition process. A vague one tells you the failure has never been considered.

Ask for pricing you can see. Programs that gate every number behind a call are often gating price variance, not protecting margin structure. And ask for all of it in writing — a supplier willing to put quality commitments in an email is a supplier who expects to honor them.

The paper trail that makes an inquiry survivable

Assume that at some point a processor, a platform, a regulator, or a large customer asks you to explain your operation. What makes that conversation short is a file, not an argument.

Keep lot numbers for everything you sell, and archive the matching COA rather than relying on a link that may change. Keep supplier invoices and any written attestations about purity, testing scope, and fulfillment origin. Keep dated captures of your own listing copy, so you can show what your pages said in a given month rather than reconstructing it. Keep a short record of your claims standard and when you last audited against it.

None of this is a substitute for advice from your own attorney, and none of it is a defense you should ever need to test. It is simply the difference between answering a question in an afternoon and hiring counsel to reconstruct two years of history. Ask your lawyer what record retention makes sense for your entity and jurisdictions.

What Real Peptides does differently

Real Peptides built its wholesale side around the assumption that the buyer will check. Compounds are tested to 99%+ HPLC purity with multi-panel batch testing, and the certificates of analysis are publicly verifiable — you can look up lab results yourself, before you apply, without a rep releasing them and without paying for the privilege. That is the opposite of the pattern resellers run into elsewhere in this category, where testing claims are unverifiable, COAs are treated as a paid extra, and pricing is hidden until you are on a call.

Fulfillment is domestic, on a published 5–7 day standard, so you are not explaining transshipment delays to your own customers. Confirm current timing when you apply. Catalog depth is real, spanning categories like performance and recovery research alongside longevity and metabolic pathway compounds, which matters if you are trying to stock core SKUs and cover a long tail without managing two suppliers.

Everything is research use only. Real Peptides does not position any compound as a human therapeutic, and does not carry the compounds most frequently asked about in that framing. Getting an account open is a 3-step wholesale application. Wholesale pricing tiers and program terms are published rather than quoted case by case, so you can model your economics before you commit inventory or route a single order.

The path if you are qualified

If you have your entity questions answered by counsel, a claims standard you can defend, and a real reason to add research compounds to your catalog, the next step is the Wholesale Partner Program application. It is short, it is reviewed, and it exists to confirm you are a business buyer rather than to create friction. Bring your volume expectations and your questions about testing documentation — those are the conversations the program is built for.

More detail on tiers, terms, and testing documentation lives on the wholesale peptides program page, and qualified businesses can apply for a wholesale account directly.